Related Experiment Video
Updated: Jul 9, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Fatal intoxication with a selective serotonin reuptake inhibitor, lorazepam, and codeine
Emily R Filter1, Laura Gorczynski, John R Fernandes
1Department of Pathology and Molecular Medicine, Hamilton Health Sciences Centre, McMaster University, Hamilton, Ontario, Canada.
Selective serotonin reuptake inhibitors (SSRIs) are linked to severe side effects and fatalities, especially when combined with other drugs. This case highlights a fatal outcome from coingesting sertraline, lorazepam, and codeine.
Area of Science:
- Pharmacology
- Toxicology
- Clinical Medicine
Background:
- Selective serotonin reuptake inhibitors (SSRIs) emerged in 1987 as treatments for depression and anxiety.
- Increased SSRI use correlates with more severe adverse events and fatalities.
- Fatalities often involve coingestion with other serotonergic agents or substances.
Observation:
- A case report details a fatality involving a patient who coingested sertraline, lorazepam, and codeine.
- This combination represents a specific instance of polypharmacy with potentially lethal consequences.
Findings:
- The coingestion of sertraline, lorazepam, and codeine led to a fatal outcome.
- The presumed mechanism of death is discussed in relation to the combined pharmacological effects.
Implications:
- Highlights the critical risk of polypharmacy involving SSRIs and central nervous system depressants/serotonergic agents.
- Underscores the importance of careful patient monitoring and medication review when prescribing SSRIs.
- Emphasizes the need for awareness regarding drug-drug interactions that can potentiate toxicity.
Related Concept Videos
CNS Depressants: Barbiturates and Benzodiazepines
Depressants
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Toxidromes: Clinical Features
CNS Depressants: Alcohol and Nicotine
Anxiolytic Drugs: Benzodiazepines and Buspirone